-+ 0.00%
-+ 0.00%
-+ 0.00%

Grown Rogue forms 51/49 New York joint venture backed by USD 15 million capital commitment

PUBT·08/25/2026 19:51:34
Listen to the news
Grown Rogue forms 51/49 New York joint venture backed by USD 15 million capital commitment
  • Grown Rogue formed Grown Rogue New York, a 51/49 joint venture with a capital partner, to pursue entry into New York.
  • Capital partner invested USD 10 million for a 49% preferred equity stake, with conversion rights starting at USD 0.55 per share.
  • Additional USD 5 million drawable term loan commitment supports total project-based financing of up to USD 15 million.
  • JV will manage PharmaCann’s New York operations under a services agreement, pending a planned acquisition of the license and assets.
  • Target purchase price about USD 4.5 million, with USD 3 million payable upon regulatory approval of the change of control.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grown Rogue International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001279569-26-000827), on August 25, 2026, and is solely responsible for the information contained therein.